Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials

Nina Kimer; Lise Lotte Gluud; Richard W. Morris; Marsha Y. Morgan

doi:10.1016/j.jceh.2017.01.105

Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials

Nina Kimer
, Lise Lotte Gluud
, Richard W. Morris
, Marsha Y. Morgan

Research output: Chapter in Book/Report/Conference proceeding › Conference Contribution (Conference Proceeding)

482 Downloads (Pure)

Original language	English
Title of host publication	17th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Symposium 2017
Publisher	Elsevier Inc.
Pages	S78-S79
Number of pages	2
DOIs	https://doi.org/10.1016/j.jceh.2017.01.105
Publication status	Published - Feb 2017

Publication series

Name	Journal of Clinical and Experimental Hepatology
Publisher	Elsevier
Number	Supplement 1
Volume	7
ISSN (Print)	0973-6883

Access to Document

10.1016/j.jceh.2017.01.105

Full-text PDF (accepted author manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier http://www.sciencedirect.com/science/article/pii/S0973688317301123?via%3Dihub. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 217 KB

Handle.net

Persistent link

Cite this

Kimer, N., Gluud, L. L., Morris, R. W., & Morgan, M. Y. (2017). Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials. In 17th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Symposium 2017 (pp. S78-S79). Article 101 (Journal of Clinical and Experimental Hepatology; Vol. 7, No. Supplement 1). Elsevier Inc.. https://doi.org/10.1016/j.jceh.2017.01.105

Kimer, Nina ; Gluud, Lise Lotte ; Morris, Richard W. et al. / Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy : A Systematic Review With Meta-Analyses of Randomised Controlled Trials. 17th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Symposium 2017. Elsevier Inc., 2017. pp. S78-S79 (Journal of Clinical and Experimental Hepatology; Supplement 1).

@inproceedings{609daa75171249c597b10f1cb5a46498,

title = "Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials",

author = "Nina Kimer and Gluud, \{Lise Lotte\} and Morris, \{Richard W.\} and Morgan, \{Marsha Y.\}",

year = "2017",

month = feb,

doi = "10.1016/j.jceh.2017.01.105",

language = "English",

series = "Journal of Clinical and Experimental Hepatology",

publisher = "Elsevier Inc.",

number = "Supplement 1",

pages = "S78--S79",

booktitle = "17th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Symposium 2017",

address = "United States",

}

Kimer, N, Gluud, LL, Morris, RW & Morgan, MY 2017, Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials. in 17th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Symposium 2017., 101, Journal of Clinical and Experimental Hepatology, no. Supplement 1, vol. 7, Elsevier Inc., pp. S78-S79. https://doi.org/10.1016/j.jceh.2017.01.105

Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials. / Kimer, Nina; Gluud, Lise Lotte; Morris, Richard W. et al.
17th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Symposium 2017. Elsevier Inc., 2017. p. S78-S79 101 (Journal of Clinical and Experimental Hepatology; Vol. 7, No. Supplement 1).

Research output: Chapter in Book/Report/Conference proceeding › Conference Contribution (Conference Proceeding)

TY - GEN

T1 - Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy

T2 - A Systematic Review With Meta-Analyses of Randomised Controlled Trials

AU - Kimer, Nina

AU - Gluud, Lise Lotte

AU - Morris, Richard W.

AU - Morgan, Marsha Y.

PY - 2017/2

Y1 - 2017/2

U2 - 10.1016/j.jceh.2017.01.105

DO - 10.1016/j.jceh.2017.01.105

M3 - Conference Contribution (Conference Proceeding)

T3 - Journal of Clinical and Experimental Hepatology

SP - S78-S79

BT - 17th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Symposium 2017

PB - Elsevier Inc.

ER -

Kimer N, Gluud LL, Morris RW, Morgan MY. Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials. In 17th International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) Symposium 2017. Elsevier Inc. 2017. p. S78-S79. 101. (Journal of Clinical and Experimental Hepatology; Supplement 1). Epub 2017 Feb 20. doi: 10.1016/j.jceh.2017.01.105